Entrada Therapeutics Reports Second Quarter 2025 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/29/2026

1. NTAP
2. SPY
3. NVDA
4. MDB
5. ORCL
6. MTN
7. AIR
8. META
9. FFAI
10. SMMT

Go back to Entrada Therapeutics Reports Second Quarter 2025 Financial Results
(NASDAQ: TRDA) Delayed: 6.26 +0.04 (0.64%)
Previous Close $6.22    52 Week High $ 
Open $6.25    52 Week Low $ 
Day High $6.43    P/E N/A 
Day Low $6.08    EPS $ 
Volume 268,575